Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast

Breast Cancer Research and Treatment

Volumn 113, Issue 1, 2009, Pages 59-66

  Green, Andrew R ^a   Krivinskas, Sophie ^a   Young, Peter ^a   Rakha, Emad A ^a   Paish, E Claire ^a   Powe, Desmond G ^a   Ellis, Ian O ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CCCTC binding factor; Dipeptidase 1; E cadherin; Laser microdissection; Lobular carcinoma in situ

Indexed keywords

UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CHROMOSOME 16Q; CONTROLLED STUDY; CTCF GENE; DERPC GENE; DPEP1 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, RIBOSOMAL, 18S;

EID: 58049196968     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9905-8     Document Type: Article

References (32)

1. ER Frykberg 1999 Lobular carcinoma in situ of the breast Breast J 5 296 303
2. KI Bland HR Menck CE Scott-Conner M Morrow DJ Winchester DP Winchester 1998 The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States Cancer 83 1262 1273
3. TM Abdel-Fatah DG Powe Z Hodi AH Lee JS Reis-Filho IO Ellis 2007 High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma Am J Surg Pathol 31 417 426
4. K Gunther S Merkelbach-Bruse BK Amo-Takyi S Handt W Schroder L Tietze 2001 Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization J Pathol 193 40 47
5. AM Cleton-Jansen 2002 E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 4 5 8
6. M Amari A Suzuki T Moriya K Yoshinaga G Amano H Sasano N Ohuchi S Satomi A Horii 1999 LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia Oncol Rep 6 1277 1280
7. Baum M (1995) Breast cancer: a guide for every women. Oxford University Press
8. EA Rakha AR Green DG Powe R Roylance IO Ellis 2006 Chromosome 16 tumor-suppressor genes in breast cancer Genes Chromosomes Cancer 45 527 535
9. JE Etzell S Devries K Chew C Florendo A Molinaro BM Ljung FM Waldman 2001 Loss of chromosome 16q in lobular carcinoma in situ Hum Pathol 32 292 296
10. EA Rakha SE Pinder CE Paish IO Ellis 2004 Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1 Br J Cancer 91 1591 1596
11. CM McIver JM Lloyd PJ Hewett JE Hardingham 2004 Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma Cancer Lett 209 67 74
12. G Berx KF Becker H Hofler F van Roy 1998 Mutations of the human E-cadherin (CDH1) gene Hum Mutat 12 226 237
13. G Berx AM Cleton-Jansen K Strumane WJ de Leeuw F Nollet F van Roy C Cornelisse 1996 E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain Oncogene 13 1919 1925
14. AA Vostrov WW Quitschke 1997 The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation J Biol Chem 272 33353 33359
15. GN Filippova S Fagerlie EM Klenova C Myers Y Dehner G Goodwin PE Neiman SJ Collins VV Lobanenkov 1996 An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes Mol Cell Biol 16 2802 2813
16. M Burcin R Arnold M Lutz B Kaiser D Runge F Lottspeich GN Filippova VV Lobanenkov R Renkawitz 1997 Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF Mol Cell Biol 17 1281 1288
17. C Kanduri V Pant D Loukinov E Pugacheva CF Qi A Wolffe R Ohlsson VV Lobanenkov 2000 Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive Curr Biol 10 853 856
18. GN Filippova CF Qi JE Ulmer JM Moore MD Ward YJ Hu DI Loukinov EM Pugacheva EM Klenova PE Grundy AP Feinberg AM Cleton-Jansen EW Moerland CJ Cornelisse H Suzuki A Komiya A Lindblom F Dorion-Bonnet PE Neiman HC Morse 3rd SJ Collins VV Lobanenkov 2002 Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity Cancer Res 62 48 52
19. JE Rasko EM Klenova J Leon GN Filippova DI Loukinov S Vatolin AF Robinson YJ Hu J Ulmer MD Ward EM Pugacheva PE Neiman HC Morse 3rd SJ Collins VV Lobanenkov 2001 Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF Cancer Res 61 6002 6007
20. EM Kozak SS Tate 1982 Glutathione-degrading enzymes of microvillus membranes J Biol Chem 257 6322 6327
21. M Sun L Ma L Xu J Li W Zhang G Petrovics M Makarem I Sesterhenn M Zhang EJ Blanchette-Mackie J Moul S Srivastava Z Zou 2002 A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumors Mol Med 8 655 663
22. Z Madjd SE Pinder C Paish IO Ellis J Carmichael LG Durrant 2003 Loss of CD59 expression in breast tumours correlates with poor survival J Pathol 200 633 639
23. KS McCarty Jr LS Miller EB Cox J Konrath KS McCarty Sr 1985 Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies Arch Pathol Lab Med 109 716 721
24. U Lehmann H Kreipe 2001 Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies Methods 25 409 418
25. R Fernandez-Gonzalez A Jones E Garcia-Rodriguez PY Chen A Idica SJ Lockett MH Barcellos-Hoff C Ortiz-De-Solorzano 2002 System for combined three-dimensional morphological and molecular analysis of thick tissue specimens Microsc Res Tech 59 522 530
26. CB Vos AM Cleton-Jansen G Berx WJ de Leeuw NT ter Haar F van Roy CJ Cornelisse JL Peterse MJ van de Vijver 1997 E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis Br J Cancer 76 1131 1133
27. MR Emmert-Buck RF Bonner PD Smith RF Chuaqui Z Zhuang SR Goldstein RA Weiss LA Liotta 1996 Laser capture microdissection Science 274 998 1001
28. TL Mastracci S Tjan AL Bane FP O'Malley IL Andrulis 2005 E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast Mod Pathol 18 741 751
29. S Aulmann H Blaker R Penzel RJ Rieker HF Otto HP Sinn 2003 CTCF gene mutations in invasive ductal breast cancer Breast Cancer Res Treat 80 347 352
30. E Austruy M Cohen-Salmon C Antignac C Beroud I Henry VC Nguyen L Brugieres C Junien C Jeanpierre 1993 Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach Cancer Res 53 2888 2894
31. JE Klaunig Y Xu JS Isenberg S Bachowski KL Kolaja J Jiang DE Stevenson EF Walborg Jr 1998 The role of oxidative stress in chemical carcinogenesis Environ Health Perspect 106 1 Suppl 289 295
32. S Hiraguri T Godfrey H Nakamura J Graff C Collins L Shayesteh N Doggett K Johnson M Wheelock J Herman S Baylin D Pinkel J Gray 1998 Mechanisms of inactivation of E-cadherin in breast cancer cell lines Cancer Res 58 1972 1977